Neimeth Announces SEC Approval to Extend Rights Issue by 15 Working Days

Image Credit: businessday.ng

August 29, 2022/NGX

We refer to our market bulletin of 3 August 2022 with reference number: NGXREG/LRD/MB48/22/08/03 whereby the market was notified that trading in Neimeth International Pharmaceuticals Plc’s Rights Issue of 2,373,947,500 ordinary shares of 50 Kobo each at N1.55 per share on the basis of five (5) new ordinary shares for every four (4) ordinary shares held as at the close of business on Friday, 22 April 2022 (Neimeth’s Rights) opened on Wednesday, 3 August 2022 and will continue until Thursday 25 August 2022. 

Neimeth International Pharmaceuticals Plc has obtained the approval of the Securities and Exchange Commission’s (SEC) to extend Neimeth’s Rights by fifteen (15) working days.

Consequently, trading in Neimeth’s Rights will now close on Thursday, 15 September 2022. 

Below are details of the Rights:

Leave a Comment

Your email address will not be published. Required fields are marked *

*